Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Hypnotherapy significantly improves symptoms in IBS patients

Hypnotherapy significantly improves quality of life in irritable bowel syndrome patients, both in the short- and long-term, claim British researchers reporting to the BSG conference.

News image

fiogf49gjkf04

Two research teams investigated the impact of hypnotherapy on quality of life in patients suffering from irritable bowel syndrome (IBS).

They presented their findings at the British Society of Gastroenterology Annual Meeting in Birmingham, England.

In the first study, investigators from the Western General Hospital in Edinburgh, Scotland, evaluated the impact of gut-directed hypnotherapy upon health-related quality of life (HRQoL) status in IBS patients.

A total of 75 IBS patients (55 females, median age 37 years) were enrolled in the trial.

The predominant symptoms among the patients were abdominal pain in 46 (61%), altered bowel habit in 24 (32%), and abdominal bloating in 5 (7%).

Hospital Anxiety and Depression Scales, and an IBS disease-specific quality of life tool (IBSQoL) were used to measure outcomes.

The researchers took measurements at baseline (pre-treatment) and at 3 months post-treatment.

There were found to be statistical improvements in all domains of the IBSQoL (emotional, mental, and physical health, sleep, energy, diet, and social and physical role) after treatment.

Improvements were most marked in female patients, particularly those with predominant abdominal pain.

Furthermore, significant improvements were seen in both males and females for anxiety and depression.

Dr G. D. Smith commented that gut-directed hypnotherapy had a very positive impact upon psychological well being and HRQoL in IBS.

This appeared most effective in patients with a predominant symptom of abdominal pain and bloating.

The authors recommended that a randomized, controlled study of hypnotherapy in IBS should be conducted.

Hypnotherapy improved symptoms and quality of life in IBS patients.
BSG
In the second study, a team from the University Hospital of South Manchester, England, conducted a long-term follow-up of IBS patients treated with hypnotherapy.

A total of 239 IBS patients, who had undergone hypnotherapy between 1 and 5 years previously, were contacted and asked to complete 3 separate questionnaires. Of these, 178 patients responded.

In a Subjective Assessment Questionnaire (assessing effects of hypnotherapy, medication use, and consultation rates) 86% of patients were found to have improved at the end of hypnotherapy (62% of whom rated symptoms as very much better).

Of the patients that improved, 83% reported that, since finishing hypnotherapy, symptoms had remained the same as at the end of hypnotherapy, or had continued to improve. However, 17% had some deterioration.

In addition, 59% of patients did not require any medication. Of those who did, 40% took it less often than previously.

Three quarters of the patients consulted their GP and/or hospital consultant less often about IBS symptoms, and 49% less about other symptoms.

All IBS measures in an IBS Questionnaire (rating severity of symptoms and QOL) remained significantly better at follow-up than before hypnotherapy. These included pain severity and frequency, bloating, bowel habit dissatisfaction, and life interference.

There was only slight deterioration in some of the measures at follow-up, compared with post-hypnotherapy.

Extra-colonic symptoms, QOL, and Hospital Anxiety and Depression scores all remained improved at follow-up.

Author W. M. Gonsalkorale said on behalf of the group, "This study confirms the long-term benefit of hypnotherapy."

"In addition, the substantial reduction of medication and consultation rates highlights the significant economic advantages of this form of treatment," it was concluded.

BSG
19 March 2002

Go to top of page Email this page Email this page to a colleague

 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Autoimmune pancreatitis in children
 01 November 2017 
Heartburn relief in adolescents with GERD
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us